Preoperative chemoradiation therapy for esophageal cancer is a risk factor for the elevation of high mobility group box-1, leading to an increase in postoperative severe pulmonary complications

HMGB1 in Cancer: Good, Bad, or Both?

(2013) R. Kang et al.   CLINICAL CANCER RESEARCH

Postoperative Serum Concentrations of High Mobility Group Box Chromosomal Protein-1 Correlates to the Duration of SIRS and Pulmonary Dysfunction Following Gastrointestinal Surgery

(2011) Risa Takahata et al.   JOURNAL OF SURGICAL RESEARCH

Elevated serum CRP levels after induction chemoradiotherapy reflect poor treatment response in association with IL-6 in serum and local tumor site in patients with advanced esophageal cancer

(2010) Hitoshi Fujiwara et al.   JOURNAL OF SURGICAL ONCOLOGY

High mobility group box-1 expression correlates with poor outcome in lung injury patients

(2009) Alessandra Bitto et al.   PHARMACOLOGICAL RESEARCH

Therapy-induced expression of NF-κB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation

(2008) J. G. Izzo et al.   DISEASES OF THE ESOPHAGUS

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE

Acute lung injury following an esophagectomy for esophageal cancer, with special reference to the clinical factors and cytokine levels of peripheral blood and pleural drainage fluid

(2007) M. Morita et al.   DISEASES OF THE ESOPHAGUS